With the growing connection between CD33 and AD, and the utility of mouse models of AD for studying mechanisms of disease pathogenesis35,36, we felt that clarifying the expression levels of mCD33 on immune cell subsets—including primary microglia—would be useful. This evidence concerns the gene CD33 and Alzheimer disease.